Table 3.
DLBCL | BL | BLU | |
---|---|---|---|
Age at presentation | Usually older but can occur at any age | Children, young adults | Older adults |
Pathogenesis | May be related to the germinal center (GCB), activated B cell or other pathway | GCB derived | GCB derived |
Growth rate | Rapid | Extremely rapid, Ki67 approaching 100% | Extremely rapid but usually less than 100% |
Stage | Even distribution, 50% stage 1 or 2 | Usually high stage | Usually advanced III/IV |
Bone marrow involvement | Uncommon, often terminal | Common | Common |
CNS involvement | Unusual | Leptomeningeal disease common at presentation in children and adults60 | Common |
EBV | Uncommon in the absence of immunodeficiency or age-related senescence | >90% in endemic BL 40% in sporadic and HIV-related BL |
Negative |
MYC translocation | Uncommon, usually a secondary event associated with a complex karyotype | Almost always present as initiating event and single abnormality (MYC simple) | Often double hits with translocations involving MYC, plus BCL2 and/or sometimes BCL6 |
Abbreviations: BL, Burkitt lymphoma; CNS, central nervous system; DLBCL, diffuse large B-cell lymphoma; EBV, Epstein-Barr virus; GCB, germinal center B cell.